Literature DB >> 18297430

Inflammatory bowel disease, past, present and future: lessons from animal models.

Atsushi Mizoguchi1, Emiko Mizoguchi.   

Abstract

Accumulating data from animal models indicate that Inflammatory bowel disease (IBD) is mediated by a much more complicated mechanism than previously predicted. For example, the role of an individual molecule in the pathogenesis of IBD distinctly differs depending on several factors, including the fundamental mechanism of induction of the disease, the target cell type, the phase of disease, and the environment. Therefore, it has been difficult in the past to fully explain the complicated mechanism. Novel concepts have recently been proposed to further explain the complicated mechanism of IBD. In this review, we introduce past, current, and possible future concepts for IBD models regarding T helper (Th) 1, Th2, and Th17, antigen sampling and presentation, regulatory cell networks, NOD2, Toll-like receptors, bacteria/epithelia interaction, stem cells, autophagy, microRNAs, and glycoimmunology, and we also discuss the relevance of these new concepts, developed at the bench (in animal models), to the bedside.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297430     DOI: 10.1007/s00535-007-2111-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  224 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

4.  Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Authors:  Kyoko Katakura; Jongdae Lee; Daniel Rachmilewitz; Gloria Li; Lars Eckmann; Eyal Raz
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis.

Authors:  Minoru Matsuura; Kazuichi Okazaki; Akiyoshi Nishio; Hiroshi Nakase; Hiroyuki Tamaki; Kazushige Uchida; Toshiki Nishi; Masanori Asada; Kimio Kawasaki; Toshiro Fukui; Hazuki Yoshizawa; Shinya Ohashi; Satoko Inoue; Chiharu Kawanami; Hiroshi Hiai; Yasuhiko Tabata; Tsutomu Chiba
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 6.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

7.  MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.

Authors:  Akihiro Araki; Takanori Kanai; Takahiro Ishikura; Shin Makita; Koji Uraushihara; Ryoichi Iiyama; Teruji Totsuka; Kiyoshi Takeda; Shizuo Akira; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2005-01       Impact factor: 7.527

8.  Role of nod2 in the response of macrophages to toll-like receptor agonists.

Authors:  Anne-Laure Pauleau; Peter J Murray
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

10.  Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Yasuyo Shimomura; Kiyotaka Nagahama; Atsushi Mizoguchi; Atul K Bhan
Journal:  Gastroenterology       Date:  2007-04-14       Impact factor: 22.682

View more
  53 in total

1.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Animal models of IBD: linkage to human disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Curr Opin Pharmacol       Date:  2010-06-08       Impact factor: 5.547

3.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 4.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

5.  Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.

Authors:  Akira Andoh; Hiroyuki Kuzuoka; Tomoyuki Tsujikawa; Shiro Nakamura; Fumihito Hirai; Yasuo Suzuki; Toshiyuki Matsui; Yoshihide Fujiyama; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

6.  Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis.

Authors:  Hiroki Saijo; Norifumi Tatsumi; Seiji Arihiro; Tomohiro Kato; Masataka Okabe; Hisao Tajiri; Hisashi Hashimoto
Journal:  Lab Invest       Date:  2015-05-04       Impact factor: 5.662

Review 7.  Roles of galectins in inflammatory bowel disease.

Authors:  Akira Hokama; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

8.  Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.

Authors:  Akira Andoh; Hirotsugu Imaeda; Tomoki Aomatsu; Osamu Inatomi; Shigeki Bamba; Masaya Sasaki; Yasuharu Saito; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2011-01-21       Impact factor: 7.527

9.  Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Authors:  Eun-Ha Joh; In-Ah Lee; Sang-Jun Han; Sunju Chae; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2009-12-03       Impact factor: 2.571

10.  The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Authors:  T Sugihara; A Kobori; H Imaeda; T Tsujikawa; K Amagase; K Takeuchi; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.